Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1)
have been demonstrated to be very specific for idiopathic membranous nephropathy (MN) …

The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …

The phospholipase A2 receptor (PLA2R) is the major target antigen (Ag) in idiopathic
membranous nephropathy (IMN). Recently, several types of immunoassay systems for anti …

The phospholipase A 2 receptor (PLA 2 R) is the major target antigen in idiopathic
membranous nephropathy. The technique for measuring antibodies against PLA 2 R and …

Recent findings in idiopathic membranous nephropathy (MN) suggest that in most patients,
the disease is because of anti-phospholipase A 2 receptor (PLA 2 R1) autoantibodies. Our …

Antibodies to the phospholipase A2 receptor 1 (PLA2R1) have been reported in 70% of
cases of idiopathic membranous nephropathy (IMN). The genetic susceptibility of IMN has …

Introduction Clinical course of membranous nephropathy (MN) is difficult to predict.
Measurement of circulating anti-PLA2R autoantibodies (PLA2R-Ab) and detection in …

Background Antibodies against M-type phospholipase A2 receptor (PLA2R) are serological
markers of disease activity in patients with idiopathic membranous nephropathy (iMN). To …

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …

Background Antibodies to M-type phospholipase A2 receptor (a-PLA2R) have been
identified in most patients with idiopathic membranous nephropathy, but the prevalence in …